Flotek Industries, Inc. (FTK) Earnings Call Transcript & Summary
August 10, 2022
Earnings Call Speaker Segments
Bernie Colson
executiveThanks, and hello to everyone on this morning's call. It's great to have you with us. Here with me and taking part in today's session are John Gibson, our Chairman, Chief Executive Officer, and President; Ryan Ezell, our Chief Operating Officer; Seham Carson, our Interim Chief Financial Officer; James Silas, our Senior Vice President of Research and Innovation; and Nick Bigney, our General Counsel and Chief Compliance Officer. During this call, we'll begin with prepared comments about our business and the results for the quarter. After that, we'll take whatever questions you may have. Our earnings announcement covering second quarter 2022 results has just been released and can be found on our website; we've also posted a refreshed investor presentation that you're invited to download and consult while we speak. Just a reminder that today's call is being webcast, and a replay will be accessible on our website as well. Keep in mind that anything we say today about projections or what we expect for future events constitutes forward-looking statements. Such statements carry a number of risks and uncertainties, many of which lie outside our control. These risks and uncertainties could lead actual results to differ materially from what we currently expect. Listeners should review our earnings release and the risk factors described in our SEC filings. Additionally, please see the reconciliations included in our earnings press release, since management might discuss non-GAAP metrics on this call. I'll hand things over now to John.
John Gibson
executiveThanks, Bernie. Hello, everybody, and I appreciate you being here as we talk about what we delivered in the second quarter of 2022. Today's report is something we've been eager to share, and we also want to give you some context regarding developments that have occurred after the quarter closed. Q2 represents the very first complete quarter in which Flotek has been running under the significant supply agreement with ProFrac, the details of which we laid out in prior months; it's a pleasure to tell you that both the contract and the transactional side of the business are picking up steam just as we anticipated, producing a sequential rise in revenue of 2.3x and a year-over-year increase of 3.2x. On top of that, our cash position has gotten considerably stronger, and our interim CFO, Seham Carson, is going to walk through that in greater depth during her comments. Just to remind you, the ProFrac contract took effect on April first; it runs for 10 years and provides for an equivalent volume from our complete portfolio of downhole chemistries sufficient to support 30 of their frac fleets, or 70% of their overall frac fleet, whichever figure is larger. Even though we're only at the beginning stages of this contract, having served an average of eight fleets during Q2, we have strong confidence in our ability to scale up to the contract's full scope across the quarters ahead. Furthermore, nothing leads us to believe that our relationship is capped by those 30 fleet or 70% figures. Since we keep delivering outstanding service, the way our arrangement is structured gives ProFrac an incentive to take as much chemistry from Flotek as possible. ProFrac just announced it is acquiring U.S. Well Services, a deal that should be finalized in Q4. Because of that, they anticipate running 44 active frac fleets once 2022 comes to a close. Basic arithmetic tells you that 70% of 44 comes to slightly under 31; even so, we absolutely believe we can capture a larger share of that business as we grow, and we're aiming for ProFrac to want to buy chemistry from us across its whole fleet. Our genuine ambition is to serve as a strategic supplier to ProFrac. For Flotek and for the industry, this agreement is demonstrating that it's transformational. Thanks to this agreement, E&Ps now possess a comprehensive, vertically integrated completion solution that lowers emissions and provides greener chemistries, which in turn safeguards air, water, land, and people. Across the coming decade, we expect this agreement to generate backlog exceeding $2 billion in revenue for Flotek, and that includes anticipated revenues above $200 million during 2023 from the ProFrac contract by itself. That figure excludes any effect stemming from ProFrac's announced purchase of U.S. Well Services. After that acquisition closes, we'll be in a position to share more context about the extra benefit we anticipate from ProFrac's larger scale. I want to keep emphasizing as well that this contract is non-exclusive, so we can bring on additional customers and keep increasing sales volumes among the remainder of our energy chemistry customers, something we've already managed to accomplish during the first half of 2022. To give you a sense of how much we've grown, during all of 2021, we delivered 19 million pounds of chemistry. During Q2 2022, we delivered 40 million pounds of chemistry in total, and 9 million pounds of that went to our transactional chemistry customers alone. In just one quarter, 9 million pounds is nearly half of what we delivered to transactional customers across the entire year. Ryan will share more specifics about our strong top-line growth when he speaks. Because of the significant sequential increase in the quarter, we pre-released our Q2 revenue numbers on July twentieth. During that announcement, we set a target of more than $28 million in revenue, and it's a pleasure to share that we could report $29.4 million, which once more equals 2.3x growth compared with Q1 and 3.2x growth compared with Q2 2021. Hitting that level of growth within the quarter fills me with pride in what the team has accomplished. It took an enormous amount of work. Our team is truly outstanding, and Q2 execution could not have been better. The growth we've delivered has created some challenges, and I want to briefly discuss our adjusted EBITDA to try to get ahead of some questions on that subject during the Q&A; on our Q1 conference call, we stressed that we anticipated higher than usual costs in the quarters ahead tied to the rapid increase in activity, essentially the ramp up. That statement turned out to be correct, and we once again flagged the higher cost in our July 20 press release. Q2's final result was an adjusted EBITDA of -$7.2 million, a slight deterioration compared with Q1. Ryan will go into greater detail on expense drivers in his remarks. In closing, we have faith in our ability to drive more flow-through down to the bottom line as we move ahead, and things are going according to plan; our commitment to reaching positive adjusted EBITDA margins stands. On a slide within the investor deck we put up on our site not long ago, you can see how our adjusted EBITDA margin has improved steadily across the last four quarters. We anticipate that this pattern will carry on during the back half of 2022 and on into 2023. Whether we succeed down the road hinges on how well we can help our customer's customer win — those being the oil and gas producers who count on what we make to get the most out of production while keeping environmental effects to a minimum. We're picking up on a shift in the marketplace right now. Buyers who used to concentrate mainly on cutting expenses are becoming more interested in how quickly wells produce at the start, getting the most out of total reserves—what we call EUR—and lowering the risk that sloppy chemical choices will harm the reservoir. That movement plays right into our strengths and where we sit in the market, and we can't wait to find out how much share we can pick up over the next several years because of it. At this point I'll hand things over to Dr. Ezell. Ryan.
Ryan Ezell
executiveThanks, John, and good morning. For Flotek, this quarter was a defining one, since the revenue growth shows our approach — being the collaborative partner of choice for sustainable, optimized chemistry and data solutions — is delivering results. Let's move straight into the highlights. As John noted, total company revenue rose 2.3x quarter over quarter and more than 3.2x versus the same period in 2021. All told, we delivered more than 40 million pounds of chemistry to our customers in Q2, which greatly exceeds the entire volume of chemistry delivered during the whole of 2021. Revenue from our transactional chemistry technologies climbed 15% sequentially. That beats the growth of the hydraulic fracturing fleet market for a fourth consecutive quarter, which signals further that our customized chemistry solutions are capturing market share. In addition, our emphasis on balance sheet metrics and preserving working capital produced a 28% decrease in days sales outstanding, a 60% decrease in days inventory outstanding, and gross inventory grew only 14% in absolute terms alongside a 128 improvement on revenue sequentially. Lastly, this ramp-up in activity came with 0 lost time incidents, 0 spills, and no discharges. I'm pleased with the strong performance Flotek turned in during the first half of this year, and I want to thank every Flotek employee for their hard work, their contribution to these outstanding results, and their dedication to collaboration, safety, and service quality. Now, transitioning into a few key details for the quarter, I'd like to talk about where things stand in our mutually beneficial partnership with ProFrac, which I'm glad to say has gotten off to a very solid start. In Q2, we wrapped up the first full quarter of contract operations, supplying downhole chemistry to an average of 8 ProFrac fleets across 4 major basins; we anticipate that figure will double to 16 or more fleets in the third quarter as we keep executing our accelerated ramp of chemical deliveries. I'd also like to take a moment to add more color on the details of the ProFrac contract that we haven't previously spent enough time discussing. While we usually talk about operational execution in terms of fleets serviced, delivered volume is the true underlying driver of the contracts. A number of assumptions are built into the contract regarding chemicals delivered, based on specific product type and geographic location. When we designed and negotiated the contract, ProFrac took a conservative approach in their assumptions about the calculated volumes per fleet. So far, the delivered volume per fleet has exceeded our expectations; put another way, it's quite possible we'll fulfill the contracted volumes at a fleet count below 30. On top of that, this offers potential upside across the 10-year life of the partnership. With such prolific increases of differentiated solutions being distributed to the well site, having proper chemical supply, manufacturing, and logistics in place is essential for successful implementation. During the downturn, we made a strategic move to an in-basin delivery approach for some high-volume chemicals, which let us get the most out of our manufacturing capacity and preserve working capital while placing key pieces of the chemical supply chain nearer to where our customers are. We've said before that we can double our manufacturing capacity utilization levels without any major capital spending. Actually, with the switch to in-basin delivery, things look even better than that, and we aren't worried at all about meeting our explosive growth without constructing new facilities. Turning now to how we did this quarter, we keep making solid headway on gaining market share and growing faster than industry activity levels. I'm especially happy that our customer base is widening with domestic and international E&P operators alike, plus service companies. That reflects our ongoing dedication to broadening our revenue mix and lowering the risk that comes with customer concentration. This covers the first field use of our integrated digital chemistry approach at the well site. During Q2, we successfully put our proprietary JP3 Verax analyzers to work on chosen fleets to assess field gas usage by tracking the quality and energy content of pipeline natural gas. Thanks to real-time monitoring of a steady gas supply, we cut diesel consumption on location by 50%-70% for the hydraulic fracturing fleets. After that, we can let dual fuel operations meet Tier 4 EPA emissions, which works out to roughly a 35% reduction compared with Tier 2. We think this will be a strong use case for safeguarding our customers' capital equipment while lowering fuel expenses and greenhouse gas emissions in the field. Even more significant, we've taken this to a commercial level with a 5-year agreement with ProFrac to roll out as many as 20 Verax units across their dual fuel fleets moving forward, and we have several opportunities of comparable scale and scope in the pipeline. I'd also point you to our recent press release for further specifics about this new commercial agreement with ProFrac; we're centered on building synergy between chemistry and digitization so our differentiated solutions can lessen chemistry's impact when it comes to total cost of ownership, along with environmental cost of ownership, for our customers and the industry, in both international and domestic markets. Put simply, our focus is on safeguarding water quality, limiting formation damage, and boosting the estimated ultimate recovery of every single completion. With an eye toward reducing risk, we keep using our growing volumes with key suppliers to lock in future purchase prices and material allocation volumes for our top product lines as we pursue accelerated growth. As our volume with suppliers rises, we'll capitalize on economies of scale to bring down costs and widen margins; that said, inflation is hitting us throughout the supply chain, but these trends are industry-wide and global, and we're tweaking our pricing to lift margin to healthier levels. There's another area I want to address, and it concerns the largest individual factor behind rising costs this quarter: freight and logistics. Our expenses for freight and logistics came in above what we had projected when the quarter started, largely because of charges tied to field deployment and mobilization for our ISO tank storage fleet. Delivered volume grew enormously, and that forced us to speed up mobilization of over 80 additional field deployment tanks into the different basins within our geographic operations. That expansion amounts to a five-fold rise versus the prior quarter; we do not anticipate this ISO deployment-related cost recurring, since we're building out bulk storage capabilities in the key active basins in the U.S., and as a result, gross margins while ramping up don't reflect what we expect once we're in the steady-state execution phase. To wrap up, my optimism about the future remains strong. Our mission excites me — delivering differentiated solutions that maximize value for our customers, all while staying committed to ESG, growing market share, and maintaining SG&A discipline. With that, I'll hand the call to Seham for the key financial highlights.
Seham Carson
executiveThanks, Ryan. To kick things off, I want to walk everyone through a few accounting items tied to our convertible notes and the ProFrac supply agreement, since these turned out to be significant in the second quarter. To start, mark-to-market adjustments on the convertible notes will require quarterly non-cash entries across the notes' one-year term. Back in Q1 2022, that adjustment came in as a non-cash loss of $3.9 million, whereas Q2 delivered a non-cash gain of $17.2 million. I'd like to dig a bit deeper here, because these figures are sizable and will keep introducing quarter-to-quarter swings into our financial results. That $3.9 million non-cash loss in Q1 2022 related to the mark-to-market adjustment on the initial $10 million of notes issued in Q1 tied to the ProFrac supply agreement, measured as of March 31st. The dramatic flip in Q2 to a non-cash gain of $17.2 million came from the extra $69 million face value of notes issued during the second quarter in connection with the supply agreement, combined with a much lower stock price on June 30 versus March 31. Put simply, when the share price falls from one quarter end to the next, we record a gain. The steeper the stock's decline, the bigger that gain becomes. I think we can all keep in mind that, once again, these entries are non-cash, and that we'll only record them through Q2 2023, or until the second tranche of convertible notes converts into equity, whichever comes first. Next, in the second quarter we recorded a $737,000 non-cash reduction to revenue tied to our ProFrac contract asset. That contract asset reflects the value of the convertible notes issued as consideration for the initial ProFrac supply agreement in Q1 plus the amendment in Q2. As of the closing dates of the two tranches, the cumulative fair value of those notes was roughly $83 million, booked as a contract asset, which gets amortized across the 10-year term of the ProFrac supply agreement and shows up as a non-cash reduction to revenue in our U.S. GAAP financials. Again, I want to stress that these are non-cash adjustments, and everyone should expect further non-cash adjustments every quarter, though their size is hard to forecast since it depends on the share price and other variables. If you'd like the details on how the convertible notes are valued, please see our SEC financials for the methodology and underlying assumptions. Now turning to the income statement in Q1. Consolidated revenue for the quarter was $29.4 million, which rose 128% versus Q1 2022 and climbed 221% versus the second quarter of last year. Stripping out the non-cash revenue reduction tied to the contract asset, revenue came to $30.1 million in Q2. Consolidated cost of goods sold reached $31.7 million, an increase of 137% from last quarter and 194% year-over-year. The main reason for these higher costs was the spending needed to get the ProFrac supply agreement up and running, which Ryan already went over. Our gross margin for Q2 2022 came in at negative $2.3 million, which is worse than the negative $0.5 million we saw in Q1 and the negative $1.6 million from Q2 2021. If you factor in that non-cash revenue reduction I mentioned earlier, gross margin for Q2 2022 would be -$1.6 million. SG&A came to $7.4 million in the second quarter of 2022, which is a 52% jump over the $4.9 million from Q1 2022 and a 77% jump over Q2 2021, because we absorbed extra costs from professional fees tied to more contract labor, consultants, and legal fees connected to the ProFrac and PIPE transactions. That said, roughly $1.7 million of those professional fees sitting in SG&A aren't something we expect to see again. Non-GAAP EBITDA for Q2 reached $8.1 million, which is an $18 million improvement over the -$9.9 million from a year ago, and also over Q2 last year's -$6.3 million. What mainly drove that big positive shift was the $17.2 million non-cash mark-to-market gain on the convertible notes. Non-GAAP adjusted EBITDA for the second quarter was a loss of $7.2 million, which is $1.8 million lower than last quarter's loss of $5.4 million and the second quarter 2021 loss of $6.7 million. Like Ryan mentioned, we found spots where Q2 performance fell short and we have a plan ready to boost adjusted EBITDA in the back half of the year. Now let's turn to the balance sheet. We closed the second quarter with $33.1 million in cash and equivalents, compared to $24.9 million at the close of the first quarter and $11.5 million at the close of 2021. That far better cash position got a favorable boost from the $20 million and $19.5 million PIPE issuances in February and June, along with several working capital metrics that improved, though this was partly offset by operating losses for the quarter, which included fees for closing the PIPE and the ProFrac supply agreement I mentioned earlier. Also, back in April 2022, as part of monetizing non-core assets, we sold our Waller, Texas facility for $4.3 million and booked a $1.9 million gain. Looking ahead to the second half of 2022 and into 2023, our aim is to keep leveraging our working capital improvements while growing top line revenue substantially; we're also still evaluating offers for our Monahans, Texas facility and expect to share an update in the quarters ahead. Even though our cash position is much stronger today than it's been, we're continuing our work with Piper Sandler on various other cash generation activities to help meet our future working capital growth needs. With that, I'll hand the call back to John for his closing remarks.
John Gibson
executiveOkay, thank you so much, Seham. Once again, I want to express appreciation to those who hold shares in our company for assisting us in opening up a remarkable chance and protecting what lies ahead for our operations through the ProFrac agreement. This marks the first occasion during my professional life that I have joined an organization possessing a backlog this strong, and I feel positive regarding our capacity to turn rising revenue into profits moving ahead. So far, our people have carried out the ramp-up without a single misstep, and they remain dedicated to maintaining that same perfect execution in the future. Just picture producing double the amount you did during the same quarter a year ago, using an identical workforce and making zero errors. These individuals are true experts. It is an honor to be among them. I truly appreciate you being on this call and for your ongoing backing, and now we are ready to take your questions.
Don Crist
analystGood morning. How's everyone doing today?
John Gibson
executivePretty good, Don. And you?
Don Crist
analystI'm getting by as well as I can. I'd like to discuss how quickly you're scaling up chemical supply to the ProFrac fleets. In your presentation, you mention roughly 16 during Q3. Should we treat that as a solid run rate moving forward, with 7 or 8 fleets added each quarter until you reach either 30 fleets or whatever number ProFrac asks you to serve?
Ryan Ezell
executiveHey, Don, Ryan Ezell here. Yeah, I'd agree. That seems to be the situation, if we consider a steady-state view of adding those 7 to 8 every quarter; we describe this using the quarter average, correct? We sort of watch it rise and dip somewhat, yet on an average basis, 8 each quarter is what we're currently anticipating.
John Gibson
executiveI think it'll be sustained until we get to the thirty-
Ryan Ezell
executiveThirty fleets, correct.
John Gibson
executive…under the initial agreement. After that, once they finalize U.S. Well, at that point we’ll collaborate with them in an effort to bring in those extra crews that arrive alongside U.S. Well.
Don Crist
analystCorrect, that matches what I figured too. Let me push that a bit further — right now, do you face any geographic restriction on what you can do? Or is it more that you can, say, pick one region to begin the rollout in, versus moving across every one of their fleets based on wherever those fleets happen to sit nationwide, for instance when they finish on one pad and move to another?
Ryan Ezell
executiveYes. At present, there are no geographic limits whatsoever on what we do. Chemistry has been provided by us in every significant basin across the U.S. as we speak, and that even covers certain work in Wyoming, where environmental rules are stricter. Those chemistries of ours are registered in that state as well. Any basin is fine for us, and nowhere their fleets might travel holds us back.
Don Crist
analystAll right. So the timing of your rollout sort of hinges on when customers roll over, right — in the gaps between pads.
Ryan Ezell
executiveThat's right.
Don Crist
analystwould not.
Ryan Ezell
executiveThat's correct.
Don Crist
analystIn terms of geography.
Ryan Ezell
executiveRight. Beyond ProFrac, this covers what we're doing internationally as well — our slickwater hydraulic fracturing operations are running abroad too. None of the geographic commitments apply to us here. It simply comes down to customers rolling over and the timing of when we pick up the fleets.
Don Crist
analystAll right. I had a question regarding JP3. Clearly, that's a solid agreement being deployed across 20 fleets with ProFrac. Could you address, first, what this means for revenue, and I'm not sure how you'd prefer to frame it, whether per quarter for each fleet, annually, or any other measure you'd choose to share, or what that market might grow into down the road. The 20 would presumably be deployed across the coming quarters, but whatever detail you can offer would be useful.
John Gibson
executiveDon, it may be somewhat early to provide revenue figures tied to JP3. Consider what ProFrac is doing — they are genuinely setting the pace in the sector when it comes to capitalizing on fuel gas through deployment of the Verax Analyzer solution. They have managed to cut diesel usage by up to 50% or beyond. Looking at that in the context of our entire industry, our view is that this isn't something limited to ProFrac. We believe this initiative ought to be implemented throughout all 270 fleets as they start transitioning to dual fuel, enabling us to lower diesel consumption, cut CO2 emissions for our sector, and truly stand as the most responsible industry anywhere when it comes to our pledge to lower greenhouse gas. JP3, in my view, is an essential piece of that approach and fits every public company.
Don Crist
analystWhen it comes to ProFrac's rollout, might you manage that during this year for the 20?
Ryan Ezell
executiveAt present, we're already operating on fleets. The bigger factor is capital acceptance into those fleets as they choose which ones will host the equipment. We're on 2 as of now, and throughout the year we'll keep rolling out until we reach the 20 range, in line with what the contract specifies.
Don Crist
analystAll right, thanks. I'll hand it back over.
Jeff Robertson
analystThanks. Morning, John and Ryan. My apologies if this came up already — my connection cut out for a few minutes. Regarding the ProFrac contract, I believe there was a volume figure tied to the frac fleets. Ryan, could you discuss the volume you're providing to ProFrac and how it stacks up against what the agreement initially envisioned?
Ryan Ezell
executiveThe contract stands out because it was set up around a specific count of fleets spread across different regions, using factors like proppant intensity and so on, to establish the baseline volumes. Right now, with the fleets we've brought online, we're running a bit above what the contract specifies per fleet. We see nothing that would interrupt this, since we're adding those fleets at a pace of roughly 7 to 8 each quarter, until we hit or go past the 30 fleets currently agreed upon.
John Gibson
executiveThey had extensive data, Jeff, and we used that data plus our experience.
Ryan Ezell
executiveRight.
John Gibson
executiveSo, figuring out the typical amount per basin. That figure changes depending on where you are geographically. Certain basins consume greater quantities of fluid than others. What's great about this is they aimed to establish a floor, allowing them to offer a commitment, and that's what they accomplished. With that floor, they stayed cautious, and we're discovering some additional potential beyond those figures; they felt sure they'd never drop beneath it, and I believe we're seeing that hold true.
Jeff Robertson
analystJohn, so does that suggest we might see some extra revenue eventually? Should that pattern keep up, could there be additional revenue beyond the contract figures you folks originally mentioned?
Ryan Ezell
executiveYeah, we're confident that opportunity exists. It's not only about the volume from those initial 30 fleets alone, since we're already running above that level, but it's also about what the U.S. Well Services team could potentially add as those fleets get brought on.
John Gibson
executiveOn top of that, like I mentioned during my remarks, there's clearly a move away from simply cutting expenses — which is the approach taken throughout COVID — toward getting the most out of the reservoir, achieving the best possible recovery, fine-tuning early output, and flattening decline curves. Achieving that genuinely calls for the more sophisticated, higher-margin nanochemicals — essentially our surfactants. We believe that's another area where our customers will push this business forward. As they do so, it will affect ProFrac and whatever their fleets require to function more as a reservoir manager rather than merely a stimulation operation. I think that points to a promising fit with where our core competencies and strengths lie.
Jeff Robertson
analystJohn and Ryan, my understanding is that for customers outside of ProFrac, you completed 9 million pounds of chemistry, versus 19 million pounds during the entirety of 2021. Could you discuss how you anticipate the expansion with non-ProFrac customers unfolding across the second half of 2022, and what visibility, at minimum, you currently have into 2023?
Ryan Ezell
executiveYes. That's a wonderful thing for us to address, since ProFrac has been the subject of so much intense debate; we feel a lot of enthusiasm about the direction our transactional core business is heading; over the past four quarters, it has grown faster quarter-over-quarter, I'd say, than the hydraulic fracturing fleet. We expect that this technology will keep gaining acceptance in the market and that we will pick up share through the remainder of 2022. We already secured some strong wins in Q3, and those deliveries will begin at the close of this month, moving into September, with others carrying over into Q4. We're also enthusiastic about growth in our international operations, since our deployment of the hydraulic fracturing slickwater fluid in the Middle East has won considerable acceptance, along with certain advanced acid stimulation chemistry we're also seeing abroad.
Jeff Robertson
analystTurning to the balance sheet — Seham, you brought up the working capital needs and that pre-funded warrant raise that closed in late June. Could you walk us through how the balance sheet stands today to handle what's required across the coming 6 to 9 months?
Seham Carson
executiveYes. Morning, and thanks for asking that. As you laid it out nicely, the money coming from the PIPE put us in a position where we can deal with this, and we're examining things very carefully as we plan alongside our suppliers, ensuring we're properly prepared on that front, along with further possibilities for financing the ramp up and everything that goes along with it.
John Gibson
executiveBasically, Jeff, every step possible is being taken by us so that the ramp up requires as little extra working capital as possible. A few quite significant items, I'd say, have been highlighted by me. Payment terms with our suppliers have been successfully lengthened, and collection terms with our customers have been shortened. On the cash flow side, those 2 things together give us support. Our view is that we have a solid forward picture regarding how this will be funded, and as the ramp up keeps going, the cash appears to be adequate.
Jeff Robertson
analystAppreciate it. I suppose this is the final question, and it's directed at Ryan or John. What I want to confirm is whether you're able to grow capacity for both Flotek and non-Flotek clients using the facilities or chemical facilities you already have, without needing any meaningful additional capital. Is that right?
Ryan Ezell
executiveAbsolutely, that's right. For our part, we're genuinely thrilled. As I mentioned, while the market was down, our big push was cutting our cost structures and figuring out how to shift our in-blending operations and sourcing nearer to the customers, in whatever geographic areas they happen to be. As we scaled up through that, we found it took a lot of strain off the primary manufacturing we run at our key sites, such as the one in Marlow, Oklahoma. Honestly, it's beating what we'd projected when it comes to how quickly we can ramp and avoid spending on any significant capital upgrades just to grow our production capacity. The reason is that today we're satisfying the full demand with just one operating shift at that site, and that's at a utilization rate of likely under 25% of all the CapEx invested there. We see enormous room to keep growing far beyond what we first anticipated, and without big capital outlays there — the only thing we'd likely need is another crew shift running overnight. We couldn't be happier with where that leaves us.
Jeff Robertson
analystGood. Thank you very much for taking my questions.
Eric Swergold
analystThank you, everyone. Could you elaborate a bit further on JP3? I realize you had already taken an accounting write-off on it, so seeing it get a second life here is a pleasant surprise. Could you elaborate—you mentioned how it reduces costs for producers, both money and diesel, but could you also discuss, or remind us, how it could help refiners cut costs, and pipeline companies too? Then a separate question, not related: you brought up international. Could you give a bit more detail about what's going on with the national oil companies in the Middle East, and how your business could grow with them? Thanks.
Ryan Ezell
executiveRegarding the JP3 technology, I'll begin by discussing what we're doing with field gas monitoring. We're quite enthusiastic about the opportunity we're carrying out with ProFrac, involving—I'd say—pipeline natural gas arriving at the hydraulic fracturing fleet and checking its quality; we think there's an enormous amount of room to expand that we can see with other—I'd say—other equipment deployed in the field, such as various compressors and so forth. That's a tremendous opportunity. As we move toward things that are more midstream and downstream, we're receiving excellent acceptance when it comes to examining transmix opportunities to stop contamination. We're seeing considerable field deployment into other areas, evaluating condensate quality, various components. We remain enthusiastic about what's happening there. What we're referencing regarding field gas pumping is a fresh opportunity that's really, really strong for us and will deliver greater promise for our digitization and the combination of our monitoring.
John Gibson
executiveEric, you don't happen to have your phone and computer on, do you?
Eric Swergold
analystNothing on my computer is making any beeping noise.
John Gibson
executiveThere's some feedback coming through on our end. Please continue. That's clearer at this point.
Ryan Ezell
executiveSo, regarding our global operations and the growth segments, there's a significant—I'd say, as we examine the national oil companies, we keep observing that reliable CAGR expansion across many of those chances. The truly thrilling aspect is that this sits at the heart of our efforts, specifically involving our surfactant and stimulation chemistry. We have excellent prospects with NOCs in Kuwait, the situation in Oman, with ADNOC in the UAE, and likewise with Saudi Aramco, applying what I'd describe as more sophisticated carbonate-style stimulations, where we seek flowback aids and also our work on slickwater trials in Saudi. Huge possibilities there. Steady, I'd say, throughout the cycle activity that will remain consistent for us going forward on the chemistry side.
Eric Swergold
analystEric, thanks for that—glad it was useful.
John Gibson
executiveJohn here—yes, on the JP3 side of Verax, ProFrac has been excellent, Eric, since you have a strategic partner in them, and when you get together, it doesn't feel like a typical sales pitch. It's a session about generating value for both sides. Once they spot a chance to create genuine value, they adopt quickly; sitting down with them is truly enjoyable when your focus is on boosting ESG results, cutting CO2, and capitalizing on the fresh fleet generation they're rolling out. What I mean is, they move fast whenever they spot a value-creating opportunity. Elsewhere, we encounter extended sales cycles featuring internal gatekeepers who aren't as centered on the basics of running a great company. Working alongside these guys is a privilege.
Eric Swergold
analystThat seems fine. I appreciate it.
Bill Hiler
analystHello there. Thanks for holding this call. I have a few things I wanted to ask about the share count. Can you tell me the fully diluted share count as of June 30, 2022? And beyond the PIK interest payments coming later, plus employee stock compensation, I'm wondering whether that figure accounts for every piece of the ProFrac contract and the PIPE? It would also help if you could tell us roughly what those PIK payments will look like in Q3 and Q4.
Nick Bigney
executiveNick here. That's a really good question. On the 10-Q, the method used to figure that share count — and all the earnings releases, for SEC purposes — only captures what has already been converted. If you look at that share figure toward the end, you've also got the convertible notes that convert next in Q1 and Q2, plus the warrants. Based on when people choose to convert, the ballpark would be — just estimating from memory — somewhere around 100 million shares, give or take. We could work out the precise calculation, and I suspect you could too. The key thing is that those aren't part of the 76 million share figure.
Bill Hiler
analystNo, what I see is roughly 124 million on a fully diluted basis on average for June 30. You likely already have a figure for the end of the quarter. That figure — which might be 130, I'm not sure — what does it assume, the fully diluted count that appears in the 10-Q and in today's press release?
Nick Bigney
executiveHonestly, I'd need to go check that figure myself. As for the numbers I currently have, the one that will appear in the 10-Q we file, presumably later today, should be approximately 7 million issued and outstanding, with about 6 million in Treasury. Aside from roughly 3 million of the convertible shares, none have converted yet, so they won't be part of that count. I'm not completely certain where the 130 million figure comes from.
John Gibson
executiveBill, we’re going to get back to you on that one, once we’ve had a chance to work through some of the assumptions and put it together.
Bill Hiler
analystOkay. I can follow up on that. What's your timeline for getting the 10-Q filed?
John Gibson
executiveIt ought to go in tonight. That's right.
Bill Hiler
analystAll right, that's excellent. Thank you, everyone, I really appreciate it.
John Gibson
executiveYes. Many thanks. I'm grateful to all of you for joining this call. I'm grateful to our shareholders for remaining with us throughout everything. At this point, you're starting to witness the value we're capable of generating. We are an outstanding chemistry company, in both molecules and digital, and we now have a chance to demonstrate that. How great we are truly hinges on how good our people are, and the people we have are excellent — they're the ones delivering this. I mean, once more, I'll just say it again: consider reaching a point where you've accomplished double what you managed in a year and a quarter with about the same number of employees; we simply have people dedicated to ensuring our success. We're eager to collaborate with you and to build some wealth for everyone too. Take care.
Operator
operatorConference is now concluded. Thank you for attending today's presentation. You may now disconnect.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Flotek Industries, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Flotek Industries, Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Flotek Industries, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.